Dean Kamen to Receive Prestigious BioMed SA Palmaz Award for Innovation in Healthcare and the Biosciences

Known for the Segway, Kamen also invented the first wearable insulin pump and
AutoSyringe,portable dialysis machine and low-cost water filter for
underdeveloped countries

SAN ANTONIO–(Business Wire)–
Internationally renowned inventor, entrepreneur and thought leader, Dean Kamen
of Manchester, NH, can add another prestigious award to his resume when he
accepts BioMed SA`s Julio Palmaz Award for Innovation in Healthcare and the
Biosciences. BioMed SA, is a non-profit corporation founded in 2005 to help grow
and promote San Antonio`s thriving healthcare and bioscience sector. The award
honors individuals or organizations that have made significant contributions to
advance the healthcare and bioscience fields. Kamen, founder of DEKA Research &
Development Corp. and of the non-profit organization FIRST(For Inspiration and
Recognition of Science and Technology), will accept the award at BioMed SA`s
annual Palmaz Award dinner to be held in San Antonio on September 17, 2009.

Dubbed the “Dean of Innovation,” Kamen has received numerous other awards for
his many, significant innovations in biosciences and engineering, including the
National Medal of Technology and Innovation, awarded in 2000 by then-President
Bill Clinton for both having advanced medical care worldwide, and for awakening
America to the excitement of science and technology. The Medal is the highest
honor for technological achievement, bestowed by the President of the United
States on America’s leading innovators.

Kamen holds more than 440 U.S. and foreign patents, including the first wearable
insulin pump, the HomeChoiceTM portable dialysis machine, the wearable
AutoSyringe that delivers accurate doses of medication throughout the day, a
low-cost water filter for under-developed countries, the Stirling hybrid
automobile engine that also produces electricity, and the SegwayTM Human
Transporter.

In 2005, Kamen was approached by a Department of Defense official about
developing a more functional prosthetic arm for soldiers returning from Iraq
with one or both arms missing. “I didn`t expect anything to come of that
meeting,” Kamen told Newsweek magazine. “This turned out to be an extraordinary
opportunity to do some extraordinary technology.”

Named the “Luke Arm” after Star Wars character Luke Skywalker, the strap-on,
surgery-free arm under development can adapt to various control schemes – from
foot pads and pull switches to more advanced methods – to suit patient
preferences.

“BioMed SA is proud to honor an innovator who has spent his whole life helping
others overcome the challenges in their lives,” said Henry Cisneros, BioMed SA
Chair and former mayor of San Antonio. “His ongoing work with the U.S. military
to develop a robotic arm to restore functionality for wounded warriors is of
special interest to San Antonio, which is becoming the home of military
medicine.”

Kamen said a greater commitment to education and cultivating a desire to learn
among young people is key to the country`s global leadership in the biosciences.
“I think we`re entering a golden age in understanding life in terms of genomics,
and there are large areas where you`re going to see breathtaking innovations in
the next five to 10 years. The innovation coming out of San Antonio will help
move us toward that golden age.”

ABOUT THE PALMAZ AWARD

The Julio Palmaz Award for Innovation in Healthcare and the Biosciences honors
individuals or organizations that have made significant contributions to
advances in the healthcare and bioscience fields. Julio Palmaz, M.D., of The
University of Texas Health Science Center in San Antonio became the inaugural
recipient and namesake of the industry award in 2006. Dr. Palmaz is widely
recognized for inventing the first commercially successful intravascular stent,
which gained a U.S. patent in 1988 and received FDA approval for use in cardiac
arteries in 1994. The Palmaz Stent revolutionized cardiac care, with more than a
million people a year undergoing coronary artery stenting to repair clogged
arteries.

ABOUT BIOMED SA

BioMed SA is a non-profit, membership-based organization, supported in part by
Bexar County and the City of San Antonio. Its mission is to organize and promote
San Antonio`s healthcare and biosciences assets to accelerate growth of the
sector and enhance San Antonio`s reputation as a City of Science and Health. The
city`s healthcare and bioscience industry has added over 23,000 net new jobs
over the past decade, significantly fueling San Antonio`s growth and employing
one out of every seven members of the city`s workforce. As America`s seventh
largest city, San Antonio is a community that embraces science and medicine. Its
vibrant health care and bioscience industry, a dominant force in the city`s
economy with an annual economic impact exceeding $16 billion, combines unique
assets and a diversity of resources with a collaborative spirit that is making a
global impact on science and health.